Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06779968Not yet recruiting
Randomised, double-blind trial of liposomal bupivacaine and ropivacaine hydrochloride liposomal suspension injection in postoperative pain (5 arms). Primary endpoint: Numerical Rating Scale Pain Score at 24 hours. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06779968.